Milestone Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.About MIST
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients.
CEOJoseph G. Oliveto
CEOJoseph G. Oliveto
Employees29
Employees29
HeadquartersMontréal, Québec
HeadquartersMontréal, Québec
Founded2003
Founded2003
Employees29
Employees29
MIST Key Statistics
Market cap124.80M
Market cap124.80M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume271.33K
Average volume271.33K
High today—
High today—
Low today—
Low today—
Open price$3.42
Open price$3.42
Volume0.00
Volume0.00
52 Week high$9.85
52 Week high$9.85
52 Week low$3.39
52 Week low$3.39
MIST Earnings
-$0.41
-$0.27
-$0.12
$0.02
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 23, Pre-Market
ActualExpected Mar 23, Pre-Market